307 related articles for article (PubMed ID: 16052225)
1. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter.
Morimoto E; Inase N; Mlyake S; Yoshizawa Y
Anticancer Res; 2001; 21(1A):329-31. PubMed ID: 11299758
[TBL] [Abstract][Full Text] [Related]
3. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
5. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements.
Kumagai T; Tanio Y; Osaki T; Hosoe S; Tachibana I; Ueno K; Kijima T; Horai T; Kishimoto T
Cancer Res; 1996 Jan; 56(2):354-8. PubMed ID: 8542591
[TBL] [Abstract][Full Text] [Related]
6. Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.
Tanaka M; Inase N; Miyake S; Yoshizawa Y
Anticancer Res; 2001; 21(1A):291-4. PubMed ID: 11299750
[TBL] [Abstract][Full Text] [Related]
7. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658
[TBL] [Abstract][Full Text] [Related]
9. Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.
Michaelsen SR; Christensen CL; Sehested M; Cramer F; Poulsen TT; Patterson AV; Poulsen HS
J Gene Med; 2012 Jul; 14(7):445-58. PubMed ID: 22576955
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.
Osaki T; Tanio Y; Tachibana I; Hosoe S; Kumagai T; Kawase I; Oikawa S; Kishimoto T
Cancer Res; 1994 Oct; 54(20):5258-61. PubMed ID: 7923150
[TBL] [Abstract][Full Text] [Related]
11. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
[TBL] [Abstract][Full Text] [Related]
12. Use of gastrin-releasing peptide promoter for specific expression of thymidine kinase gene in small-cell lung carcinoma cells.
Inase N; Horita K; Tanaka M; Miyake S; Ichioka M; Yoshizawa Y
Int J Cancer; 2000 Mar; 85(5):716-9. PubMed ID: 10699954
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
Song JS; Kim HP
Oncol Rep; 2004 Aug; 12(2):443-7. PubMed ID: 15254714
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
15. Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells.
Ishiwata N; Inase N; Fujie T; Tamaoka M; Yoshizawa Y
Anticancer Res; 2003; 23(2B):1405-9. PubMed ID: 12820402
[TBL] [Abstract][Full Text] [Related]
16. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
17. Consequences of chemoresistance for the herpes simplex virus thymidine kinase/ganciclovir-induced bystander effect in a human small cell lung cancer cell line model.
Van Dillen IJ; Mulder NH; Sluiter WJ; Meijer C; De Jong S; Loncarek J; Mesnil M; De Vries EF; Vaalburg W; Hospers GA
Anticancer Res; 2005; 25(1A):255-61. PubMed ID: 15816546
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene.
Markowitz S; Krystal G; Lebacq-Verheyden AM; Way J; Sausville EA; Battey J
J Clin Invest; 1988 Sep; 82(3):808-15. PubMed ID: 2843572
[TBL] [Abstract][Full Text] [Related]
19. Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas.
Akerstrom V; Chen C; Lan MS; Breslin MB
Cancer Gene Ther; 2012 Dec; 19(12):828-38. PubMed ID: 23079673
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]